RESEARCH TRIANGLE PARK, NC - September 15, 1997 - Quintiles Transnational Corp. (Nasdaq: QTRN) today announced the opening of an office in Moscow, Russia, further expanding its presence in Eastern Europe. Quintiles currently is managing clinical trials in Russia and more than 10 other countries in Central and Eastern Europe.Speaking at dedication ceremonies held today in Moscow, Dennis Gillings, Ph.D., Chairman and Chief Executive Officer of Quintiles Transnational Corp., said: "The opening of this office is tangible evidence of the strong relationships we've developed over the years with Russian regulatory authorities, leading Russian medical centers and medical opinion leaders.

"Russia and other countries of Central and Eastern Europe offer us excellent opportunities to meet our customers' needs for high-quality studies delivered within tight timelines. Our presence in Moscow enhances our ability to meet that demand working side-by-side with our Russian colleagues."

Quintiles currently has a total of 60 staff members managing clinical trials in Russia, Poland, the Czech Republic, Slovakia, Hungary, Bulgaria, Belarus, Romania, Serbia, Croatia, Slovenia, Greece, and Turkey.

Quintiles currently has 10 staff members in Russia: nine in its Moscow office and one in St. Petersburg. The Moscow office address is: 1 Tverskaya Yamskaya 23, 125047 Moscow, Russia. Phone: 7095 721 1964. Fax: 7095 721 1966.

Quintiles' operations in Central and Eastern Europe are overseen from Quintiles' office in Vienna, Austria, by Dr. Heinz Carmann, M.D., Managing Director of Quintiles GesmbH. Its Russian operations are managed by Dr. Natalia Fetkovska, M.D., Ph.D., Clinical Operations Manager.

Quintiles Transnational Corp. is the market leader in providing full-service contract research, sales and marketing services to the worldwide pharmaceutical, biotechnology and medical device industries, and provides healthcare policy consulting and health information management services to the healthcare industry. Quintiles is headquartered near Research Triangle Park, North Carolina, and has more than 8,500 employees in 68 operating units in 24 countries.